108 related articles for article (PubMed ID: 10996000)
1. Immunomagnetic selection of CD34(+) cells for transplantation from partially matched family donors in children.
Toporski J; Turkiewicz D; Kałwak K; Rybka B; Ryczan R; Bogusławska-Jaworska J
Transplant Proc; 2000 Sep; 32(6):1419-21. PubMed ID: 10996000
[No Abstract] [Full Text] [Related]
2. Impact of leukapheresis cell composition on immunomagnetic cell selection with the Baxter Isolex 300i device: a statistical analysis.
Perotti C; Del Fante C; Viarengo GL; Bergamaschi P; Tinelli C; Bellotti L; Marchesi A; Parisi C; Salvaneschi L
Stem Cells Dev; 2004 Aug; 13(4):350-6. PubMed ID: 15345128
[TBL] [Abstract][Full Text] [Related]
3. Automated CD34+ cell isolation of peripheral blood stem cell apheresis product.
Spohn G; Wiercinska E; Karpova D; Bunos M; Hümmer C; Wingenfeld E; Sorg N; Poppe C; Huppert V; Stuth J; Reck K; Essl M; Seifried E; Bönig H
Cytotherapy; 2015 Oct; 17(10):1465-71. PubMed ID: 25981397
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic bone marrow stem cell transplantation following CD34+ immunomagnetic enrichment in patients with inherited metabolic storage diseases.
Gaipa G; Dassi M; Perseghin P; Venturi N; Corti P; Bonanomi S; Balduzzi A; Longoni D; Uderzo C; Biondi A; Masera G; Parini R; Bertagnolio B; Uziel G; Peters C; Rovelli A
Bone Marrow Transplant; 2003 May; 31(10):857-60. PubMed ID: 12748661
[TBL] [Abstract][Full Text] [Related]
5. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
[TBL] [Abstract][Full Text] [Related]
6. Mobilization, collection, and immunomagnetic selection of peripheral blood CD34 cells in recovered aplastic anemia patients.
Sloand EM; Read EJ; Scheinberg P; Tang Y; More K; Leitman SF; Maciejewski J; Young NS
Transfusion; 2007 Jul; 47(7):1250-3. PubMed ID: 17581160
[TBL] [Abstract][Full Text] [Related]
7. Purification of human hemopoietic stem cells for transplantation in Thailand.
Udomsakdi-Auewarakul C; U-pratya Y; Chongkolwatana V; Tanphaichitr VS; Pattanapanyasat K; Issaragrisil S
Asian Pac J Allergy Immunol; 2000 Jun; 18(2):85-92. PubMed ID: 10928620
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of CD34(+) cell isolation techniques in healthy donors.
Sousa RS; Avila A; Sousa ME; Barbosa IL; Carvalhais A
Transplant Proc; 2000 Dec; 32(8):2675. PubMed ID: 11134757
[No Abstract] [Full Text] [Related]
9. Human G-CSF-mobilized CD34-positive peripheral blood progenitor cells can stimulate allogeneic T-cell responses: implications for graft rejection in mismatched transplantation.
van Rhee F; Jiang YZ; Vigue F; Kirby M; Mavroudis D; Hensel NF; Agarwala V; Clave E; Childs R; Raptis A; Sloand E; Carter C; Read EJ; Barrett J
Br J Haematol; 1999 Jun; 105(4):1014-24. PubMed ID: 10554815
[TBL] [Abstract][Full Text] [Related]
10. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
[TBL] [Abstract][Full Text] [Related]
11. CML leukapheresis products can be enriched for CD34+ cells and simultaneously depleted of CD15+ cells using a simple Ab cocktail.
Richmond LJ; Alcorn MJ; Pearson C; Cameron G; Thomas T; Eaves CJ; Eaves AC; Holyoake TL
Cytotherapy; 2002; 4(5):407-13. PubMed ID: 12473207
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous immunomagnetic CD34+ cell selection and B-cell depletion in peripheral blood progenitor cell samples of patients suffering from B-cell non-Hodgkin's lymphoma.
Mohr M; Dalmis F; Hilgenfeld E; Oelmann E; Zühlsdorf M; Kratz-Albers K; Nolte A; Schmitmann C; Onaldi-Mohr D; Cassens U; Serve H; Sibrowski W; Kienast J; Berdel WE
Clin Cancer Res; 2001 Jan; 7(1):51-7. PubMed ID: 11205918
[TBL] [Abstract][Full Text] [Related]
13. Immunomagnetic selection of CD34(+) cells carried out in cryopreserved cell concentrates from a paediatric patient affected with non-Hodgkin lymphoma.
Zinno F; Landi F; Aureli V; Cometa AM; Scerpa MC; Caniglia M; Pinto RM; Rana I; Balduino G; Miele MJ; Isacchi G
Transfus Med; 2010 Aug; 20(4):283-6. PubMed ID: 20136780
[No Abstract] [Full Text] [Related]
14. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
Mohr M; Hilgenfeld E; Fietz T; Hoppe B; Koenigsmann M; Hoffmann M; Knauf WU; Cassens U; Sibrowski W; Kienast J; Thiel E; Berdel WE
Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736
[TBL] [Abstract][Full Text] [Related]
15. Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation.
Singhal S; Powles R; Kulkarni S; Treleaven J; Sirohi B; Millar B; Shepherd V; Saso R; Rowland A; Long S; Cabral S; Horton C; Mehta J
Bone Marrow Transplant; 2000 Mar; 25(5):501-5. PubMed ID: 10713626
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma.
Samaras P; Pfrommer S; Seifert B; Petrausch U; Mischo A; Schmidt A; Schanz U; Nair G; Bargetzi M; Taverna C; Stupp R; Stenner-Liewen F; Renner C
Biol Blood Marrow Transplant; 2015 Jan; 21(1):74-80. PubMed ID: 25278456
[TBL] [Abstract][Full Text] [Related]
17. Positive immunomagnetic CD34(+) cell selection in haplo-identical transplants in beta-thalassemia patients: removal of platelets using an automated system.
Zinno F; Landi F; Aureli V; Balduino G; Lanti A; Sodani P; Adorno G; Lucarelli G; Isacchi G
Cytotherapy; 2010; 12(1):60-6. PubMed ID: 19929454
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation across major genetic barriers: the role of megadose stem cells and nonalloreactive donor anti-third party CTLS.
Bachar-Lustig E; Reich-Zeliger S; Gur H; Zhao Y; Krauthgamer R; Reisner Y
Transplant Proc; 2001 May; 33(3):2099-100. PubMed ID: 11377465
[No Abstract] [Full Text] [Related]
19. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1.
Dreger P; Viehmann K; Steinmann J; Eckstein V; Müller-Ruchholtz W; Löffler H; Schmitz N
Exp Hematol; 1995 Feb; 23(2):147-54. PubMed ID: 7530212
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT.
Urbano-Ispizua A; Solano C; Brunet S; de la Rubia J; Odriozola J; Zuazu J; Figuera A; Caballero D; Martínez C; García J; Sanz G; Torrabadella M; Alegre A; Pérez-Oteiza J; Jurado M; Oyonarte S; Sierra J; García-Conde J; Rozman C
Bone Marrow Transplant; 1998 Sep; 22(6):519-25. PubMed ID: 9758337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
